The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
4
- 1
Reader, Jason Antony
Director born in August 1972Individual (61 offsprings)Officer
2017-10-11 ~ dissolvedOF - Director → CIF 0 - 2
Price, Emma Carys
Director born in August 1993Individual (28 offsprings)Officer 2023-10-06 ~ dissolvedOF - Director → CIF 0 - 3
6-8, Doshomachi 2-chome, Chuo-ku, Osaka,541-0045, Osaka, JapanCorporate (5 offsprings)Person with significant control 2019-12-27 ~ dissolvedPE - Ownership of shares – 75% or more → CIF 0PE - Right to appoint or remove directors → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0 - 4
VISTRA COSEC LIMITED
- nowJORDAN COSEC LIMITED - 2019-04-05First Floor, Templeback, 10 Temple Back, Bristol, United KingdomActive Corporate (4 parents)Equity (Company account)1 GBP2024-12-31Officer 2017-10-11 ~ dissolvedOF - Secretary → CIF 0
Ceased
4
- 1
Masson, Sunil
Director born in November 1971Individual (72 offsprings)Officer 2019-08-16 ~ 2022-08-05OF - Director → CIF 0 - 2
Anstock, Reuben James
Commercial Director born in November 1981Individual (7 offsprings)Officer 2018-01-30 ~ 2019-08-16OF - Director → CIF 0 - 3
Craig, Mark
Chartered Secretary born in May 1974Individual (4 offsprings)Officer 2022-08-05 ~ 2023-10-06OF - Director → CIF 0 - 4First Floor Templeback, 10 Temple Back, Bristol, United KingdomDissolved Corporate (6 parents)Officer2017-10-11 ~ 2018-01-30PE - Director → CIF 0
Company in focus
ALTAVANT SCIENCES HOLDINGS LIMITED
Previous name
PULMOVANT HOLDINGS LIMITED - 2018-06-29
Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Average Number of Employees
02020-04-01 ~ 2021-03-31
02019-04-01 ~ 2020-03-31
Par Value of Share
Class 1 ordinary share
12020-04-01 ~ 2021-03-31
Nominal value of shares issued in a specific share issue
Class 1 ordinary share
1 USD2020-04-01 ~ 2021-03-31
Administrative Expenses
-24,885 USD2020-04-01 ~ 2021-03-31
-22,022 USD2019-04-01 ~ 2020-03-31
Profit/Loss on Ordinary Activities Before Tax
-24,885 USD2020-04-01 ~ 2021-03-31
-22,022 USD2019-04-01 ~ 2020-03-31
Profit/Loss
-24,885 USD2020-04-01 ~ 2021-03-31
-22,022 USD2019-04-01 ~ 2020-03-31
Comprehensive Income/Expense
-24,885 USD2020-04-01 ~ 2021-03-31
-22,022 USD2019-04-01 ~ 2020-03-31
Fixed Assets - Investments
167,184 USD2021-03-31
20,441 USD2020-03-31
Debtors
176,632 USD2021-03-31
100,421 USD2020-03-31
Net Current Assets/Liabilities
40,081 USD2021-03-31
61,709 USD2020-03-31
Total Assets Less Current Liabilities
207,265 USD2021-03-31
82,150 USD2020-03-31
Equity
Called up share capital
20,563 USD2021-03-31
20,562 USD2020-03-31
20,560 USD2019-03-31
Share premium
249,997 USD2021-03-31
99,998 USD2020-03-31
Retained earnings (accumulated losses)
-63,295 USD2021-03-31
-38,410 USD2020-03-31
-16,388 USD2019-03-31
Equity
207,265 USD2021-03-31
82,150 USD2020-03-31
4,172 USD2019-03-31
Issue of Equity Instruments
Called up share capital
1 USD2020-04-01 ~ 2021-03-31
2 USD2019-04-01 ~ 2020-03-31
Issue of Equity Instruments
150,000 USD2020-04-01 ~ 2021-03-31
100,000 USD2019-04-01 ~ 2020-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-24,885 USD2020-04-01 ~ 2021-03-31
-22,022 USD2019-04-01 ~ 2020-03-31
Audit Fees/Expenses
6,045 USD2020-04-01 ~ 2021-03-31
11,681 USD2019-04-01 ~ 2020-03-31
Tax Expense/Credit at Applicable Tax Rate
-4,728 USD2020-04-01 ~ 2021-03-31
-4,184 USD2019-04-01 ~ 2020-03-31
Investments in Group Undertakings
Cost valuation
167,184 USD2021-03-31
20,441 USD2020-03-31
Additions to investments
146,743 USD2021-03-31
Investments in Group Undertakings
167,184 USD2021-03-31
20,441 USD2020-03-31
Called-up share capital (not paid)
Current
173,943 USD2021-03-31
100,421 USD2020-03-31
Prepayments
Current
2,689 USD2021-03-31
Debtors
Current, Amounts falling due within one year
176,632 USD2021-03-31
Amounts falling due within one year, Current
100,421 USD2020-03-31
Trade Creditors/Trade Payables
Current
4,181 USD2021-03-31
2,276 USD2020-03-31
Amounts owed to group undertakings
Current
119,895 USD2021-03-31
20,441 USD2020-03-31
Accrued Liabilities
Current
12,475 USD2021-03-31
15,995 USD2020-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
20,563 shares2021-03-31
Profit/Loss
Retained earnings (accumulated losses)
-24,885 USD2020-04-01 ~ 2021-03-31
ALTAVANT SCIENCES HOLDINGS LIMITED
InfoPULMOVANT HOLDINGS LIMITED - 2018-06-29Registered number 110073167th Floor 50 Broadway, London SW1H 0DBPRIVATE LIMITED COMPANY incorporated on 2017-10-11 and dissolved on 2025-02-04 (7 years 3 months). The company status is Dissolved.The last date of confirmation statement was made at 2024-10-10CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.